长沙晚报掌上长沙9月22日讯（全媒体记者 刘军）22日开盘，*ST高鸿被直接按在跌停板上，面值只有 0.46元/股，这也是该股票连续16个交易日面值低于1元/股。即使接下来4个交易日均涨停，其股价也不 可能回到1元/股。因此，该股已经提前锁定面值退市（连续20个交易日面值低于1元/股）。记者发现， 21日晚间，*ST高鸿发布公告称，公司股票存在可能因股价低于面值被终止上市的风险。 *ST高鸿的主营业务为面向企业客户的企业信息化业务；面向3C卖场、中小企业客户的IT销售业务以及 面向个人消费者为主的信息服务业务。2025年中报，公司每股收益-0.12元，归母净利润-14034.09万 元，净利润同比增长率-3166.01%。记者注意到，截至8月20日，该公司股东户数为5.3万户。 截至9月21日，年内已有超10家A股公司因财务造假被证监会行政处罚而实质触发重大违法强制退市标 准，最终退市类型涵盖重大违法类、交易类、规范类及财务类。而去年52家退市公司中，仅新海退和退 市博天触及重大违法强制退市。 2025年8月8日，*ST高鸿公告，公司收到证监会下发的行政处罚事先告知书（简称"告知书"），认定公 司连续多年财务 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 锁定面值退市。 *ST高鸿（维权）（000851）9月21日晚间公告，公司股票存在可能因股价低于面值被终止上市的风 险。截至2025年9月19日，公司股票收盘价格已经连续15个交易日均低于1元。根据《深圳证券交易所股 票上市规则》（简称《股票上市规则》）第9.2.1条、第9.1.15条相关规定，在深交所仅发行A股股票的 公司，通过深交所交易系统连续20个交易日的股票收盘价均低于1元，深交所终止其股票上市交易；因 触及交易类强制退市情形而终止上市的股票不进入退市整理期。敬请广大投资者注意投资风险。 与此同时，公司股票还可能被实施重大违法强制退市。公司于2025年8月8日收到中国证监会下发的《行 政处罚事先告知书》（简称《告知书》）。根据《告知书》的认定，公司2020年非公开发行股票构成欺 诈发行、2015年至2023年年度报告存在虚假记载，将触及《股票上市规则》第9.5.1条第一项、第9.5.2条 第一款第（六）项规定的重大违法强制退市情形，可能被实施重大违法强制退市。根据《股票上市规 则》，如根据正式的处罚决定书结论，公司触及重大违法强 ...

锁定面值退市。 *ST高鸿（000851）9月21日晚间公告，公司股票存在可能因股价低于面值被终止上市的风险。截至2025年9月19日，公司股票收 盘价格已经连续15个交易日均低于1元。 根据《深圳证券交易所股票上市规则》（简称《股票上市规则》）第9.2.1条、第9.1.15条 相关规定，在深交所仅发行A股股票的公司，通过深交所交易系统连续20个交易日的股票收盘价均低于1元，深交所终止其股票上市 交易；因触及交易类强制退市情形而终止上市的股票不进入退市整理期。敬请广大投资者注意投资风险。 与此同时，公司股票还可能被实施重大违法强制退市。公司于2025年8月8日收到中国证监会下发的《行政处罚事先告知书》(简称 《告知书》)。 根据《告知书》的认定，公司2020年非公开发行股票构成欺诈发行、2015年至2023年年度报告存在虚假记载，将触 及《股票上市规则》第9.5.1条第一项、第9.5.2条第一款第（六）项规定的重大违法强制退市情形，可能被实施重大违法强制退市。 根据《股票上市规则》，如根据正式的处罚决定书结论，公司触及重大违法强制退市情形，公司股票将被终止上市。截至本公告披露 日，公司尚未收到正式的处罚决定书 ...

关于公司股票存在可能因股价低于面值被终止上市的风险提示 公告 证券代码：000851 证券简称：*ST 高鸿 公告编号：2025-108 大唐高鸿网络股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 特别提示： 收盘价为 0.98 元/股，公司股票收盘价首次低于 1 元。根据《深圳证券交易所股 票上市规则(2025 年修订)》第 9.2.3 条的规定，上市公司首次出现股票收盘价 低于 1 元情形的，应当在次一交易日开市前披露公司股票或者存托凭证可能被终 止上市的风险提示公告。敬请广大投资者注意投资风险。 控制的有效性进行了审计，并出具了无法表示的审计意见。公司 2021 年至 2023 年度连续三个会计年度经审计扣除非经常性损益前后净利润孰低者为负值，且 所股票上市规则（2023 年 8 月修订）》第 9.8.1 条第（四）项、第（七）项的 规定，公司股票已于 2024 年 05 月 06 日被实施其他风险警示（ST）。 规则》（2024 年修订）第 9.8.1 条第（六）项的规定，公司股票被叠加实施"其 他风险警示"。 根据《深圳证券交易所股票上 ...

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. faces significant risks of forced delisting due to major violations and financial issues, including false reporting of revenue and profits from 2020 to 2023 [4]. Group 1: Major Violation Delisting Risk - The company received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) for falsely inflating operating income, costs, and profits, which may lead to forced delisting [4]. - The company’s stock has been under risk warning since July 14, 2025, due to the potential for major violations leading to termination of listing [1][4]. Group 2: Financial Delisting Risk - The 2024 financial report received a disclaimer of opinion from the auditing firm, triggering financial delisting risks under the Shanghai Stock Exchange rules [1][2]. - The company is currently under risk warning due to financial issues, including the inability to express an opinion on internal controls [2]. Group 3: Other Risk Warnings - The company is facing additional risk warnings due to non-operational fund occupation by related parties, which violates stock exchange regulations [2]. - The company has also encountered operational risks, including a contract termination with a medical product distributor, affecting sales [2]. Group 4: Investor Advisory - The company urges investors to be cautious and rational in their investment decisions, especially given the recent abnormal stock price fluctuations that do not align with deteriorating fundamentals [4].

*ST苏吴还提示风险称，7月13日，公司收到中国证监会下发的《行政处罚事先告知书》，公司股票已 于7月14日起被叠加实施退市风险警示。如根据中国证监会正式的处罚决定书结论，公司触及重大违法 强制退市情形，公司股票将被终止上市。 北京商报讯（记者 丁宁）8月14日晚间，*ST苏吴（600200）发布公告称，公司股票8月14日收盘价为 0.99元/股，低于1元。根据《上海证券交易所股票上市规则》第9.2.1条第一款第一项规定，在上交所仅 发行A股股票的上市公司，如果连续20个交易日的每日股票收盘价均低于1元，公司股票可能被上交所 终止上市交易。 ...

Group 1 - The core point of the article is that Jiyuan Holdings Group Co., Ltd. (*ST Jiyuan) will be delisted from the Shenzhen Stock Exchange on May 29, 2025, due to triggering mandatory delisting rules after its stock price remained below 1 yuan for 20 consecutive trading days [1][3] - The company has experienced continuous losses since 2019, with a cumulative net profit loss exceeding 3.2 billion yuan from 2019 to 2023 [3] - Jiyuan Holdings has faced significant goodwill impairment risks, totaling over 1.5 billion yuan from 2019 to 2024, which has directly contributed to its net profit losses [3] Group 2 - The company was originally known as Tonghua Shuanglong Chemical Co., Ltd. and transitioned to the pharmaceutical sector in 2014 through the acquisition of Jinbao Pharmaceutical [3] - Since its rebranding in 2017, the company has aggressively pursued mergers and acquisitions, acquiring over ten companies within three years, leading to a dual business model of "chemicals + pharmaceuticals" [3] - In 2024, the company's revenue declined by 3.69%, and its losses expanded to 439 million yuan [3] Group 3 - As of 2025, a total of 11 companies have been delisted from the A-share market, with *ST Jiyuan being one of them, alongside others like *ST Meixun and *ST Bo Xin [4] - The reasons for delisting include breaches of face value, market value, voluntary delisting applications, and forced delisting due to major violations [4]

Core Viewpoint - *ST Jiyao (300108) has been decided to be delisted by the Shenzhen Stock Exchange due to triggering mandatory delisting conditions, with the delisting date set for May 29, 2025 [1][2]. Summary by Sections Company Announcement - On May 28, 2025, *ST Jiyao announced that its stock would be terminated from listing by the Shenzhen Stock Exchange, effective May 29, 2025, without entering a delisting adjustment period [1]. - The company received the termination notice on May 26, 2025, and is required to ensure its shares can enter the National Equities Exchange and Quotations (NEEQ) within 45 trading days after delisting [1]. Shareholder Information - As of March 31, 2025, *ST Jiyao had 28,056 shareholders [2]. Stock Trading Activity - Prior to its suspension on April 24, 2025, *ST Jiyao's stock price was reported at 0.21 CNY per share. On the last trading day before suspension, the stock opened at a limit-down price of 0.19 CNY, briefly rising to 0.23 CNY with a turnover rate of 29.42%, and a total trading volume of nearly 40 million CNY [4]. - The stock experienced significant price fluctuations, with a cumulative price drop deviation of 30% over two consecutive trading days and 50% over four trading days, indicating severe abnormal trading conditions [4]. Company Background - *ST Jiyao, established in 2000, operates in the pharmaceutical industry, including manufacturing, wholesale, retail, and healthcare services. The company transitioned from a chemical focus to pharmaceuticals through acquisitions starting in 2014 [6]. - The company has faced continuous losses since 2019, with a reported revenue of 333.33 million CNY in 2024, a decrease of 3.69% year-on-year, and a net loss of 439.43 million CNY, worsening from a loss of 349.31 million CNY in the previous year [6][7]. Financial Performance - As of the end of 2024, *ST Jiyao's total assets were approximately 1.44 billion CNY, down 24.52% from the previous year, and the net assets attributable to shareholders were negative 776.52 million CNY, a decline of 176.66% [7]. - In the first quarter of 2025, the company reported a revenue of 63.74 million CNY, a year-on-year decrease of 15.53%, and a net loss of 45.17 million CNY, compared to a loss of 40.85 million CNY in the same period last year [8].

Core Viewpoint - Four companies, *ST Xulan, *ST Jiayu, *ST Dongfang, and *ST Furun, have been delisted from the A-share market due to their stock prices being below 1 RMB for 20 consecutive trading days, indicating severe financial distress and regulatory issues [1][2][3]. Group 1: Company Summaries - *ST Xulan (000040) specializes in photovoltaic power generation technology and equipment. The company faced delisting after its stock price fell to 0.49 RMB, with a market capitalization of 729 million RMB. The actual controller is under investigation for information disclosure violations, worsening the company's operational difficulties [1]. - *ST Jiayu (300117) focuses on energy-efficient building products. The company reported a significant decline in revenue, with a net profit of -5.48 million RMB and a non-recurring net profit of -165 million RMB in Q1 2025. Additionally, it has new enforcement information totaling 50.2 million RMB, highlighting its financial risks [2]. - *ST Dongfang (600811) operates in modern agriculture and health food. The company’s stock price fell below 1 RMB, and it is under investigation for false disclosures in its annual reports from 2020 to 2023. The projected net profit for 2024 is expected to be between -800 million and -1.2 billion RMB [2]. - *ST Furun (600070) is involved in internet services. The company reported a net loss of 361 million RMB for 2024, although this was a 36.45% improvement year-on-year. In Q1 2025, the net loss was 10.1 million RMB, indicating ongoing financial struggles [3]. Group 2: Market Trends - There is a growing concern as other A-share companies, such as *ST Pengbo and *ST Jiu You, have also seen their stock prices drop below 1 RMB, with *ST Pengbo at 0.62 RMB and *ST Jiu You at 0.96 RMB, indicating a potential trend of financial instability among listed companies [3].

Core Viewpoint - Multiple companies, including *ST旭蓝, *ST嘉寓, *ST东方, and *ST富润, have received termination notices for their stock listings due to continuous trading prices below 1 yuan, leading to their stocks being delisted on April 30, 2025 [3][4][8][9]. Group 1: *ST旭蓝 - *ST旭蓝's stock will be delisted on April 30, 2025, following a decision from the Shenzhen Stock Exchange due to its stock price being below 1 yuan for 20 consecutive trading days [3][4]. - The company has appointed 长城国瑞证券有限公司 as its main broker to assist with the delisting process and related services [4][5]. - The company focuses on green industries, aiming to become a leading comprehensive service provider in environmental and renewable energy sectors [5]. Group 2: *ST嘉寓 - *ST嘉寓's stock will also be delisted on April 30, 2025, after receiving a termination notice from the Shenzhen Stock Exchange [3][8]. - The company has engaged 山西证券股份有限公司 as its main broker to facilitate the delisting and related transactions [8]. - *ST嘉寓 specializes in building energy efficiency, smart technology, and renewable energy solutions [8]. Group 3: *ST东方 and *ST富润 - *ST东方's stock will be delisted on April 30, 2025, following a decision from the Shanghai Stock Exchange due to similar reasons of price decline [9]. - The company has appointed 江海证券有限公司 as its main broker for the delisting process [9]. - *ST富润 will also face delisting on the same date, with the company yet to appoint a main broker for the process [9]. Group 4: Market Context - The recent trend shows an increase in companies facing delisting due to stock prices falling below 1 yuan, indicating a potential risk for other companies in the market [9][10].